FDA approves redesign of endoscope tied to infections

(HealthDay)—A redesigned Olympus TJF-Q180V duodenoscope (a type of endoscope) that has a reduced chance of spreading infection has been approved by the U.S. Food and Drug Administration.

According to an FDA news release, Olympus is voluntarily recalling the older version of the duodenoscope, an instrument used to drain fluid from blocked pancreatic and biliary ducts without the need for more . These ducts could be blocked by , gallstones or other gastrointestinal conditions, the agency said.

Duodenoscopes are used in more than a half-million procedures each year. The Olympus device was redesigned because "there is evidence that some have been associated with the transmission of infectious agents, including antibiotic-resistant infections," the FDA said.

The device's "elevator channel sealing mechanism" was modified to "create a tighter seal and reduce the potential for leakage of patient fluids and tissue" into the device, the agency said.

Olympus is recalling the original TJF-Q180V to replace the elevator channel sealing mechanism at the top of the scope, a 4-day process Olympus says should be done throughout the United States by August 2016. Until each scope is modified, may continue to use the scope, but should carefully follow the maker's instructions, the FDA said.

Olympus also will perform an annual inspection on each scope to identify any erosion of the elevator channel and replace potentially contaminated parts, the agency said.


Explore further

Maker of device in 'superbug' outbreak lacked FDA clearance (Update)

More information: The FDA has more about this action.

Copyright © 2016 HealthDay. All rights reserved.

Citation: FDA approves redesign of endoscope tied to infections (2016, January 18) retrieved 15 October 2019 from https://medicalxpress.com/news/2016-01-fda-redesign-endoscope-tied-infections.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more